| Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management M Harbord, R Eliakim, D Bettenworth, K Karmiris, K Katsanos, U Kopylov, ... Journal of Crohn's and Colitis 11 (7), 769-784, 2017 | 1271* | 2017 |
| Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels F Magro, J Lopes, P Borralho, S Lopes, R Coelho, J Cotter, FD de Castro, ... Gut 68 (4), 594-603, 2019 | 111* | 2019 |
| Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point‐of‐care quantitative test with two established ELISA assays J Afonso, S Lopes, R Gonçalves, P Caldeira, P Lago, H Tavares de Sousa, ... Alimentary Pharmacology & Therapeutics 44 (7), 684-692, 2016 | 61* | 2016 |
| Corrigendum: Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management M Harbord, R Eliakim, D Bettenworth, K Karmiris, K Katsanos, U Kopylov, ... Journal of Crohn's and Colitis 11 (12), 1512-1512, 2017 | 40 | 2017 |
| Development and validation of risk matrices for Crohn’s disease outcomes in patients who underwent early therapeutic interventions CC Dias, PP Rodrigues, R Coelho, PM Santos, S Fernandes, P Lago, ... Journal of Crohn's and Colitis 11 (4), 445-453, 2017 | 33 | 2017 |
| Comparing the continuous Geboes score with the Robarts histopathology index: definitions of histological remission and response and their relation to faecal calprotectin levels F Magro, J Lopes, P Borralho, S Lopes, R Coelho, J Cotter, ... Journal of Crohn's and Colitis 14 (2), 169-175, 2020 | 30 | 2020 |
| The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn’s disease that parallels a simple endoscopic index and fecal calprotectin J Roseira, AR Ventosa, HT de Sousa, J Brito United European Gastroenterology Journal 8 (10), 1208-1216, 2020 | 29 | 2020 |
| Accuracy of faecal calprotectin and neutrophil gelatinase B-associated lipocalin in evaluating subclinical inflammation in UlceRaTIVE colitis—the ACERTIVE study F Magro, S Lopes, R Coelho, J Cotter, F Dias de Castro, ... Journal of Crohn's and Colitis 11 (4), 435-444, 2017 | 29 | 2017 |
| Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence country M Areia, S Alves, D Brito, A Cadime, R Carvalho, S Saraiva, S Ferreira, ... Journal of Gastrointestinal and Liver Diseases 23, 371-378, 2014 | 27 | 2014 |
| Anaemia in patients with inflammatory bowel disease-a nationwide cross-sectional study F Portela, P Lago, J Cotter, R Gonçalves, H Vasconcelos, P Ministro, ... Digestion 93 (3), 214-220, 1960 | 27 | 1960 |
| Sexual quality of life in inflammatory bowel disease: a multicenter, national-level study J Roseira, F Magro, S Fernandes, C Simões, F Portela, AI Vieira, M Patita, ... Inflammatory Bowel Diseases 26 (5), 746-755, 2020 | 25 | 2020 |
| Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis F Magro, J Lopes, P Borralho, CC Dias, J Afonso, P Ministro, M Santiago, ... Journal of Crohn's and Colitis 14 (7), 1021-1025, 2020 | 24 | 2020 |
| A systematic review of factors affecting quality of life after postmastectomy breast reconstruction in women with breast cancer H Sousa, S Castro, J Abreu, MG Pereira Psycho‐Oncology 28 (11), 2107-2118, 2019 | 24 | 2019 |
| New cross-sectional imaging in IBD HT de Sousa, J Brito, F Magro Current Opinion in Gastroenterology 34 (4), 194-207, 2018 | 22 | 2018 |
| Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays J Afonso, S Lopes, R Gonçalves, P Caldeira, P Lago, H Tavares de Sousa, ... Therapeutic advances in gastroenterology 9 (6), 781-794, 2016 | 21 | 2016 |
| Clinical performance of an infliximab rapid quantification assay F Magro, J Afonso, S Lopes, R Coelho, R Gonçalves, P Caldeira, P Lago, ... Therapeutic Advances in Gastroenterology 10 (9), 651-660, 2017 | 20 | 2017 |
| Impact of early surgery and immunosuppression on Crohn's disease disabling outcomes F Magro, CC Dias, R Coelho, PM Santos, S Fernandes, C Caetano, ... Inflammatory Bowel Diseases 23 (2), 289-297, 2017 | 20 | 2017 |
| Histologic features of colon biopsies (Geboes score) associated with progression of ulcerative colitis for the first 36 months after biopsy F Magro, C Alves, J Lopes, S Lopes, HT de Sousa, J Cotter, VM da Silva, ... Clinical Gastroenterology and Hepatology 19 (12), 2567-2576. e9, 2021 | 19 | 2021 |
| A simple approach to confirm the presence of anti-D in sera with presumed anti-D+ C specificity F Baía, E Muñiz-Diaz, N Boto, M Salgado, R Montero, T Ventura, H Sousa, ... Blood Transfusion 11 (3), 449, 2013 | 18 | 2013 |
| Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays J Afonso, HT de Sousa, I Rosa, J Carvalho, CC Dias, F Magro Therapeutic Advances in Gastroenterology 10 (9), 661-671, 2017 | 17 | 2017 |
Fernando MagroVerified email at med.up.pt
